Journal
THERAPEUTIC DRUG MONITORING
Volume 35, Issue 1, Pages 78-83Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/FTD.0b013e318274197e
Keywords
efavirenz; genetics; pharmacokinetics; CYP2B6; constitutive androstane receptor; smoking; polymorphisms
Funding
- Thai Government
- AstraZeneca
- Merck
- UK Medical Research Council
- UK Department of Health Biomedical Research Centre for Microbial Diseases
- MRC [G0800247] Funding Source: UKRI
- Medical Research Council [G0800247, G0700654B] Funding Source: researchfish
Ask authors/readers for more resources
Objective: To explore the effect of demographics and single-nucleotide polymorphisms in cytochrome P450 (CYP) 2B6, 2A6, UDP-glucuronosyltransferase (UGT) 2B7, and the constitutive androstane receptor (CAR) genes on efavirenz pharmacokinetics in a Chilean cohort affected with human immunodeficiency virus. Methods: Timed plasma samples obtained throughout the dosing interval were analyzed for efavirenz concentrations with liquid chromatography/tandem mass spectrometry. DNA from whole-blood samples was used for genetic analysis. Data were analyzed using a Mann-Whitney statistical test; furthermore, a Pearson or Spearman correlation was used. A multivariate analysis was then conducted using multiple linear regression by best subset analysis. Results: Overall 219 patients were included, 208 patients had measurable efavirenz levels and available genetic samples. The overall median (interquartile range) of efavirenz concentration was 2.6 (2.1-3.7) mcg/mL. In multivariate regression analysis, CYP2B6 516G>T (P<0.0001) and CAR rs2307424 C>T (P = 0.002) were significantly related to efavirenz plasma concentrations. Conclusion: This novel association between CAR rs2307424 and efavirenz plasma concentrations now requires validation in other cohorts.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available